Dr. Harvey A. Fishman, Stanford-Trained MD PhD Ophthalmologist Entrepreneur
Dr. Fishman is Stanford-Trained MD PhD Ophthalmologist Entrepreneur
Sunday, June 12, 2011
New drugs in the pipeline drugs for Macular Degeneration
Anti-VEGF Therapy
Radiation Therapy.
Vascular Stabilization.
Complement Inhibition.
Tyrosine Kinase Inhibition.
Nicotine Cholinergic Receptor Antagonist Therapy.
Integrin Antagonist Therapy.
Gene Therapy.
Vascular Disruption.
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)